Haryana Health Minister Anil Vij has indicated the private hospitals to make self-regulatory rules after the state government cancelled the licence of the blood bank and pharmacy of the Fortis hospital at Gurugram.
"With the action against Fortis Hospital, corporate-type hospitals should get a message that they make self-regulatory rules. Only minting money should not be the aim of hospitals," Vij told ANI on Sunday.
The licences were cancelled after irregularities were found in the hospital's blood bank and pharmacy.
"After the death of a girl due to dengue, a three-member committee was sent to Gurugram's Fortis hospital. In its report, the committee stated there were irregularities in the hospital's pharmacy and blood bank, following which we have cancelled the license of the blood bank and the pharmacy," Vij said.
He said that the committee also informed about other irregularities against the hospital and action will be taken against it by other departments.
"For further action against the hospital, the health department has written to the Police and Haryana Urban Development Authority (HUDA), which had provided land for the hospital. We also wrote to the Indian Medical Association (IMA) about other irregularities and have asked for the status report," Vij said.
The committee has alleged several irregularities, including refusal of an appropriate ambulance service to the patient, not following leave against medical advice (LAMA) protocol, and overcharging.
According to the IMA protocol, a patient is discharged against the medical advice then the hospital arranges or advises for an ambulance that could provide similar conditions.
"The ambulance in which the girl was being transported had no such facilities. An Advanced Life Support (ALS) ambulance should have been used. But Basic Life Support (BLS) ambulance was provided which had no such facilities," Vij told ANI on December 6.
Parents of the seven-year-old girl, who died on November 21 of Dengue Shock Syndrome (DSS), had alleged that the Fortis Hospital charged Rs 16 lakh for the 15-day treatment.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
